MedTrace Logo

Study to Evaluate the Efficacy of an Avocado Dietary Supplement

NCT07354308 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-21

No results posted yet for this study

Summary

This 16-week, randomized, triple-blinded, placebo-controlled study evaluates the effects of an avocado dietary supplement (Metavo) on healthy weight and blood glucose management in overweight adults. The study includes body measurements, questionnaires, blood tests, and CGM monitoring to assess metabolic outcomes and participant-reported perceptions of well-being.

Conditions

Interventions

DIETARY_SUPPLEMENT

Metavo Supplement

Participants will take 8 Intervention capsules per day (4 in the morning, 4 in the afternoon)

DIETARY_SUPPLEMENT

Placebo

Participants will take 8 placebo capsules per day (4 in the morning, 4 in the afternoon)

Sponsors & Collaborators

  • Citruslabs

    collaborator INDUSTRY

  • SP Nutraceuticals Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-01-31
Completion
2026-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07354308 on ClinicalTrials.gov